The global dimethoate market is currently navigating a complex period of regulatory recalibration, with its valuation of $350 million in 2024 projected to reach $510 million by 2033 at a CAGR of 4.3%, despite facing significant headwinds from stringent bans in key agricultural regions. While the Asia-Pacific region rem...